{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:53Z","timestamp":1790858753214,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["P30DK017047"],"award-info":[{"award-number":["P30DK017047"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RRG 715234"],"award-info":[{"award-number":["RRG 715234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK017047"],"award-info":[{"award-number":["P30DK017047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR40864"],"award-info":[{"award-number":["R01AR40864"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR44533"],"award-info":[{"award-number":["R01AR44533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ymthe.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T02:11:55Z","timestamp":1644286315000},"page":"2176-2185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-2135","authenticated-orcid":false,"given":"Niclas E.","family":"Bengtsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Crudele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Klaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Halbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hauschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.02.003_bib1","series-title":"Duchenne Muscular Dystrophy","author":"Emery","year":"2003"},{"key":"10.1016\/j.ymthe.2022.02.003_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib3","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1093\/hmg\/ddv420","article-title":"Progress and prospects of gene therapy clinical trials for the muscular dystrophies","volume":"25","author":"Bengtsson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.02.003_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physiol.00012.2019","article-title":"CRISPR for neuromuscular disorders: gene editing and beyond","volume":"34","author":"Young","year":"2019","journal-title":"Physiology"},{"key":"10.1016\/j.ymthe.2022.02.003_bib5","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/ncomms16007","article-title":"Corrigendum: muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.02.003_bib6","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.02.003_bib8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ymthe.2020.11.003","article-title":"Dystrophin gene-editing stability is dependent on dystrophin levels in skeletal but not cardiac muscles","volume":"29","author":"Bengtsson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib9","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","article-title":"CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in\u00a0vitro and in\u00a0vivo","volume":"26","author":"Duch\u00eane","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib10","doi-asserted-by":"crossref","first-page":"e124297","DOI":"10.1172\/jci.insight.124297","article-title":"AAV CRISPR editing rescues cardiac and muscle function for 18\u00a0months in dystrophic mice","volume":"3","author":"Hakim","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2022.02.003_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.02.003_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.02.003_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.02.003_bib15","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1038\/mtna.2015.58","article-title":"Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method","volume":"5","author":"Iyombe-Engembe","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2022.02.003_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of novel micro-dystrophins with enhanced functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/mt.2008.28","article-title":"Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice","volume":"16","author":"Gregorevic","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib19","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2022.02.003_bib20","doi-asserted-by":"crossref","first-page":"e13228","DOI":"10.15252\/emmm.202013228","article-title":"Targeted genome editing in\u00a0vivo corrects a Dmd duplication restoring wild-type dystrophin expression","volume":"13","author":"Maino","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","article-title":"Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR\/Cas9 system","volume":"7","author":"Lattanzi","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2022.02.003_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.9.2.493","article-title":"Satellite cell of skeletal muscle fibers","volume":"9","author":"Mauro","year":"1961","journal-title":"J.\u00a0Biophys. Biochem. Cytol."},{"key":"10.1016\/j.ymthe.2022.02.003_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.celrep.2019.03.105","article-title":"In situ modification of tissue stem and progenitor cell genomes","volume":"27","author":"Goldstein","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2022.02.003_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","article-title":"In\u00a0vivo gene editing of muscle stem cells with adeno-associated viral vectors in a mouse model of Duchenne muscular dystrophy","volume":"19","author":"Kwon","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.02.003_bib25","doi-asserted-by":"crossref","first-page":"14038","DOI":"10.1038\/mtm.2014.38","article-title":"Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells","volume":"1","author":"Arnett","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.02.003_bib26","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in\u00a0vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.02.003_bib27","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.02.003_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1538\/expanim.52.93","article-title":"Canine X-linked muscular dystrophy in Japan (CXMDJ)","volume":"52","author":"Shimatsu","year":"2003","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ymthe.2022.02.003_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(88)90206-7","article-title":"Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies","volume":"88","author":"Valentine","year":"1988","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2022.02.003_bib30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.mt.6300161","article-title":"Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression","volume":"15","author":"Wang","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2012.111","article-title":"Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies","volume":"20","author":"Wang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/mt.2012.283","article-title":"Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy","volume":"21","author":"Shin","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib33","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.02.003_bib34","doi-asserted-by":"crossref","first-page":"e8647","DOI":"10.1371\/journal.pone.0008647","article-title":"A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping","volume":"5","author":"Walmsley","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.02.003_bib35","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI136873","article-title":"Correction of muscular dystrophies by CRISPR gene editing","volume":"130","author":"Chemello","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.02.003_bib36","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/S0021-9258(19)39599-7","article-title":"Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility","volume":"265","author":"Koenig","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.02.003_bib37","first-page":"14","article-title":"The structure and function of dystrophin","author":"Abmayr","year":"2006"},{"key":"10.1016\/j.ymthe.2022.02.003_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0888-7543(92)90210-J","article-title":"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy","volume":"13","author":"Sharp","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2022.02.003_bib39","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","article-title":"Antisense oligonucleotide-induced exon skipping restores dystrophin expression in\u00a0vitro in a canine model of DMD","volume":"13","author":"McClorey","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2022.02.003_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.0.CO;2-0","article-title":"Alternative dystrophin gene transcripts in golden retriever muscular dystrophy","volume":"21","author":"Schatzberg","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2022.02.003_bib42","doi-asserted-by":"crossref","first-page":"e69194","DOI":"10.1371\/journal.pone.0069194","article-title":"Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice","volume":"8","author":"Echigoya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.02.003_bib43","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/hmg\/10.24.2745","article-title":"Suppression of revertant fibers in mdx mice by expression of a functional dystrophin","volume":"10","author":"Crawford","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.02.003_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<91::AID-MUS12>3.0.CO;2-3","article-title":"Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin prduced only a relatively small increase of dystrophin-positive membrane","volume":"21","author":"Kinoshita","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2022.02.003_bib45","first-page":"54","article-title":"Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies","volume":"49","author":"Beggs","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2022.02.003_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.134.4.873","article-title":"Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a \"mild Becker\" phenotype","volume":"134","author":"Corrado","year":"1996","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2022.02.003_bib47","doi-asserted-by":"crossref","first-page":"e95918","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2022.02.003_bib48","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm.3628","article-title":"Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice","volume":"20","author":"Wein","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib49","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1212\/WNL.44.12.2388","article-title":"Becker muscular dystrophy with onset after 60 years","volume":"44","author":"Heald","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2022.02.003_bib50","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.1992.03480190051030","article-title":"Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study","volume":"267","author":"Chamberlain","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2022.02.003_bib51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.003_bib52","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.02.003_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/mt.2009.294","article-title":"Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging","volume":"18","author":"Wang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.02.003_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-1-4939-7374-3_18","article-title":"AAV6 vector production and purification for muscle gene therapy","volume":"1687","author":"Halbert","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2022.02.003_bib57","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mt.2008.102","article-title":"Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs","volume":"16","author":"Parker","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hum.2006.093","article-title":"Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy","volume":"18","author":"Wang","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.003_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmicb.2011.00220","article-title":"Immune responses to rAAV6: the influence of canine parvovirus vaccination and neonatal administration of viral vector","volume":"2","author":"Arnett","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2022.02.003_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fmicb.2011.00201","article-title":"Immunity and AAV-mediated gene therapy for muscular dystrophies in large animal models and human trials","volume":"2","author":"Wang","year":"2011","journal-title":"Front. Microbiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:05:53Z","timestamp":1778616353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1525001622000867"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.003","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}